Home>>Funding
May 2019
We have been awarded a collaborative grant from the Cancer Research Center Zurich. This collaboration between Jean-Pierre Bourquin group at the University Hospital Zurich and our group aims to elucidate the molecular mechanisms of the transcriptional circuitries controlled by the the chimeric fusion transcription factor TCF3-HLF that drives a lethal leukemia with fatal outcome.
December 2018
Swiss Cancer Research grant
We have been awarded of a 3-year grant from the Swiss Cancer Research foundation to continue our study on the molecular mechanisms of aggressive prostate cancer.
April 2018
ERC Advanced Grant
We have been awarded a prestigious ERC Advanced Grant from the European Research Council to investigate the role of nucleolus in the organization of the genome and its contribution to higher-order gene regulation.
More info can be found in the news release from UZH:
January 2018
Grant from Novartis Foundation for Medical-Biological Research awarded
We have been awarded of a grant from Novartis Medical-Biological Research to develop methods to study molecular mechanisms of aggressive prostate cancer
March 2017
Swiss National Science Foundation
We have been awarded of a 4-year SNSF grant to elucidate mechanisms of chromatin regulation in stem cells.
May 2017
Sinergia from Swiss National Science Foundation
We have been awarded of a grant from SNSF-Sinergia program for an interdisciplinary project aimed to establish regenerative strategies for heart disease via targeting the long noncoding transcriptome. This is a collaborative project together with Thierry Pedrazzini (University of Lausanne), Rory Johnson (University of Bern) and Mauro Giacca (International Centre for Genetic Engineering and Biotechnology, ICGEB, Trieste).
June 2017
Grant from Eurostars Programme
We received funding from the Eurostars Programme, which is a joint initiative between EUREKA and the European Commission, specifically dedicated to R&D-performing SMEs. We are collaborating with PolyGene AG, together with TargetEx Kft. (Hungary) and Intelligent Pharma (Spain) on gene regulation tools, and to successfully bring these expression systems to the market.
November 2016
Grant from Swiss National Center of Competence in Research RNA & Disease
We have been awarded of a grant from Swiss National Center of Competence in Research RNA & Disease to study the role of ncRNAs in prostate cancer.
